文献速递流行病学与生物统计真实世界研究与卫生经济

五大洲21个国家中年成人常见疾病、住院与死亡的差异(PURE):一项前瞻性队列研究

Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study.
PubMed 文献 · Lancet · 2019-09-03

PURE研究为前瞻性人群队列,纳入21个国家35-70岁成人162534名,中位随访9.5年,评估心血管病、癌症、损伤、呼吸系统疾病及住院和死亡的发生率。结果显示心血管病是全球主要死因,但高收入国家及部分中高收入国家癌症死亡已超过心血管病死亡,低收入国家总死亡率最高。

要点

  • 心血管病是总体最常见死因(40%),但在高收入国家仅占死亡的23%。
  • 低收入国家总死亡率(13.3/1000人年)为中等收入国家(6.9)的两倍、高收入国家(3.4)的四倍。
  • 高收入国家癌症死亡与心血管病死亡之比为0.4,低收入国家为3.0,死因构成呈过渡。

核心结论

  • 在35-70岁成人中,心血管病是全球主要死因,但高收入国家和部分中高收入国家癌症死亡已比心血管病死亡更常见,提示中年死因构成正在转变。
  • 随着许多国家心血管病减少,癌症可能成为主要死因;较贫困国家的高死亡率与危险因素无关,可能与就医可及性较差有关。

研究设计与样本

  • PURE研究为前瞻性、人群为基础的队列研究,纳入五大洲21个国家35-70岁个体。
  • 本分析评估PURE核心研究前两阶段于2005年1月6日至2016年12月4日入组的162534名参与者,中位随访9.5年(IQR 8.5-10.9)。
  • 主要结局为致死性和非致死性心血管病、癌症、损伤、呼吸系统疾病及住院的发生率,并按每1000人年计算年龄和性别标化发生率。

主要发现

  • 随访期间11307名(7.0%)参与者死亡,9329名(5.7%)发生心血管病,5151名(3.2%)发生癌症,4386名(2.7%)因损伤需住院,2911名(1.8%)发生肺炎,1830名(1.1%)发生慢性阻塞性肺疾病(COPD)。
  • 心血管病在低收入国家(7.1例/1000人年)和中等收入国家(6.8例/1000人年)比高收入国家(4.3例/1000人年)更常见;癌症、损伤、COPD和肺炎在高收入国家最常见、低收入国家最少见。
  • 总死亡率在低收入国家(13.3例死亡/1000人年)是中等收入国家(6.9例死亡/1000人年)的两倍,是高收入国家(3.4例死亡/1000人年)的四倍;除癌症外所有死因均呈低收入国家最高、高收入国家最低的模式,癌症死亡率在各收入水平国家相似。
  • 心血管病是总体最常见死因(40%),但在高收入国家仅占死亡的23%(中等收入国家41%、低收入国家43%),尽管高收入国家心血管病危险因素更多(按INTERHEART风险评分)而低收入国家最少。
  • 心血管病死亡与癌症死亡之比在高收入国家为0.4、中等收入国家为1.3、低收入国家为3.0,四个中高收入国家(阿根廷、智利、土耳其和波兰)呈现与高收入国家相似的比值;首次住院率和心血管病药物使用率在低收入国家最低、高收入国家最高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To our knowledge, no previous study has prospectively documented the incidence of common diseases and related mortality in high-income countries (HICs), middle-income countries (MICs), and low-income countries (LICs) with standardised approaches. Such information is key to developing global and context-specific health strategies. In our analysis of the Prospective Urban Rural Epidemiology (PURE) study, we aimed to evaluate differences in the incidence of common diseases, related hospital admissions, and related mortality in a large contemporary cohort of adults from 21 HICs, MICs, and LICs across five continents by use of standardised approaches. METHODS: The PURE study is a prospective, population-based cohort study of individuals aged 35-70 years who have been enrolled from 21 countries across five continents. The key outcomes were the incidence of fatal and non-fatal cardiovascular diseases, cancers, injuries, respiratory diseases, and hospital admissions, and we calculated the age-standardised and sex-standardised incidence of these events per 1000 person-years. FINDINGS: This analysis assesses the incidence of events in 162 534 participants who were enrolled in the first two phases of the PURE core study, between Jan 6, 2005, and Dec 4, 2016, and who were assessed for a median of 9·5 years (IQR 8·5-10·9). During follow-up, 11 307 (7·0%) participants died, 9329 (5·7%) participants had cardiovascular disease, 5151 (3·2%) participants had a cancer, 4386 (2·7%) participants had injuries requiring hospital admission, 2911 (1·8%) participants had pneumonia, and 1830 (1·1%) participants had chronic obstructive pulmonary disease (COPD). Cardiovascular disease occurred more often in LICs (7·1 cases per 1000 person-years) and in MICs (6·8 cases per 1000 person-years) than in HICs (4·3 cases per 1000 person-years). However, incident cancers, injuries, COPD, and pneumonia were most common in HICs and least common in LICs. Overall mortality rates in LICs (13·3 deaths per 1000 person-years) were double those in MICs (6·9 deaths per 1000 person-years) and four times higher than in HICs (3·4 deaths per 1000 person-years). This pattern of the highest mortality in LICs and the lowest in HICs was observed for all causes of death except cancer, where mortality was similar across country income levels. Cardiovascular disease was the most common cause of deaths overall (40%) but accounted for only 23% of deaths in HICs (vs 41% in MICs and 43% in LICs), despite more cardiovascular disease risk factors (as judged by INTERHEART risk scores) in HICs and the fewest such risk factors in LICs. The ratio of deaths from cardiovascular disease to those from cancer was 0·4 in HICs, 1·3 in MICs, and 3·0 in LICs, and four upper-MICs (Argentina, Chile, Turkey, and Poland) showed ratios similar to the HICs. Rates of first hospital admission and cardiovascular disease medication use were lowest in LICs and highest in HICs. INTERPRETATION: Among adults aged 35-70 years, cardiovascular disease is the major cause of mortality globally. However, in HICs and some upper-MICs, deaths from cancer are now more common than those from cardiovascular disease, indicating a transition in the predominant causes of deaths in middle-age. As cardiovascular disease decreases in many countries, mortality from cancer will probably become the leading cause of death. The high mortality in poorer countries is not related to risk factors, but it might be related to poorer access to health care. FUNDING: Full funding sources are listed at the end of the paper (see Acknowledgments).

来源:Lancet,查看原文。版权归原作者所有。

引用

  1. Dagenais GR, Leong DP, Rangarajan S, et al. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study. Lancet. 2019. PMID: 31492501. doi:10.1016/S0140-6736(19)32007-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。